Journal profile · Pathology

Annals of Diagnostic Pathology

ISSN 1092-9134 · eISSN 1532-8198 · W.B. Saunders Ltd · UNITED STATES · Bimonthly · Founded 1997

Annals of Diagnostic Pathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.58; hybrid open access; APC about USD 3,580; median 32 days to acceptance (102 articles, last 24 months); community-reported acceptance: easy; 122 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.58Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time32 daysMedian, submission to acceptance · 102 articles, last 24 months · PubMed
APCUSD 3,580Hybrid journal: charged only for open-access articles
AcceptanceEasyCommunity average
Articles per year1222025 · OpenAlex count

Scope

Aims, scope and focus

Annals of Diagnostic Pathology is published by W.B. Saunders Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Diverse Scientific and Economic Studies and Salivary Gland Tumors Diagnosis and Treatment, together about 21.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

A peer-reviewed journal devoted to the publication of articles dealing with traditional morphologic studies using standard diagnostic techniques and stressing clinicopathological correlations and scientific observation of relevance to the daily practice of pathology. Special features include pathologic-radiologic correlations and pathologic-cytologic correlations.

From the journal's Aims & Scope

Research area (LetPub): Pathology

Editor-in-chief Oluwole FadarePublisher website

Editorial board by country: none in mainland China; most named United States 45, United Kingdom 4, Czechia 3, Thailand 2, Germany 1 (56 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Sarcoma Diagnosis and TreatmentMedicine9.3%
  2. Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7%
  3. Salivary Gland Tumors Diagnosis and TreatmentMedicine5.4%
  4. Human auditory perception and evaluationEngineering4.8%
  5. Educational Robotics and EngineeringComputer Science4.7%
  6. Lymphoma Diagnosis and TreatmentMedicine4.6%
  7. Soft tissue tumor case studiesMedicine4.5%
  8. Renal cell carcinoma treatmentMedicine4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPathologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPathologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPathologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.58LetPub ·
Impact factor (publisher)
1.6Publisher website ·
CiteScore 2026-06
3LetPub ·
CiteScore (publisher)
3Publisher website ·
SJR 2026-06
0.53LetPub ·
SNIP 2026-06
0.64LetPub ·
h-index
49LetPub ·
h-index
79OpenAlex ·
i10-index
1,404OpenAlex ·
2-year mean citedness
1.52OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
15.46%LetPub ·

Volume

Articles per year
101LetPub ·

Articles by year OpenAlex count · 3,036 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026911911
202512220158
202411926334
202310822478
202216027892
2021146261,329

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

32 daysMedian, submission to acceptance · P25–P75 21 days – 43 days

Acceptance to online
median 2 days (102 articles)
Submission to online
median 34 days
Sample
102 articles with submission and acceptance dates (263 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·
Submission to first decision
6 daysPublisher website ·
First decision after review
18 daysPublisher website ·
Submission to acceptance
36 daysPublisher website ·
Acceptance to publication
3 daysPublisher website ·
Peer review
Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 3,580 / EUR 3,350 / GBP 2,870 / JPY 444,030——
Publisher websiteUSD 3,860——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare5 items from the author guidelines
Abstract
≤ 250 words
Keywords
1–7
Reference style
Numbered, in order of citation
Highlights
Required
Graphical abstract
Optional
Publisher website · model-extracted, each line checked against the text
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
AI use Declaration of generative AI use

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

Source ↗Publisher website ·
Authorship Group authorship

Authorship criteria Model summary

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

Source ↗Publisher website ·
Conflicts of interest Declaration of competing interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

Source ↗Publisher website ·
Publication ethics

Publishing ethics Model summary

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

Source ↗Publisher website ·
License & copyright License options

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

Source ↗Publisher website ·
Open access Open access

We refer you to our open access information page to learn about open access options for this journal.

Source ↗Publisher website ·
Peer review Peer review

Single anonymized review process Model summary

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

Source ↗Publisher website ·
Preprints Preprints

Preprint sharing Model summary

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
W.B. Saunders Ltd
Country or region
UNITED STATES
Language
English
Frequency
Bimonthly
Founded
1997
ISSN
1092-9134
Electronic ISSN
1532-8198
Official links

FAQ

Frequently asked questions about Annals of Diagnostic Pathology

What CAS zone is Annals of Diagnostic Pathology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Annals of Diagnostic Pathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Annals of Diagnostic Pathology?

The latest impact factor listed by LetPub is 1.58; CiteScore 3, h-index 79.

How long does peer review take at Annals of Diagnostic Pathology?

Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 32 days (interquartile range 21–43 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Annals of Diagnostic Pathology?

According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Annals of Diagnostic Pathology based?

Of the 56 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (45), United Kingdom (4) and Czechia (3). Counted from the institutions listed on the board page; for reference only.

Which databases index Annals of Diagnostic Pathology?

According to LetPub and DOAJ records, Annals of Diagnostic Pathology is indexed in SCIE and Scopus.

Is Annals of Diagnostic Pathology open access, and what is the APC?

Annals of Diagnostic Pathology is a hybrid journal. For open-access publication: APC about USD 3,580.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .